Differences in efficacy and cytokine profiles following echinocandin or liposomal amphotericin B monotherapy or combination therapy for murine pulmonary or systemic Aspergillus flavus infections
about
Amphotericin B- and voriconazole-echinocandin combinations against Aspergillus spp.: Effect of serum on inhibitory and fungicidal interactionsGenetic Diversity and In Vitro Antifungal Susceptibility of 200 Clinical and Environmental Aspergillus flavus Isolates.Delay of antifungal therapy influences the outcome of invasive aspergillosis in experimental models of infection.Toxicity and efficacy differences between liposomal amphotericin B formulations in uninfected and Aspergillus fumigatus infected mice.An immunomodulatory activity of micafungin in preclinical aspergillosis.Macrophage Activation Marker Neopterin: A Candidate Biomarker for Treatment Response and Relapse in Visceral Leishmaniasis.
P2860
Differences in efficacy and cytokine profiles following echinocandin or liposomal amphotericin B monotherapy or combination therapy for murine pulmonary or systemic Aspergillus flavus infections
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Differences in efficacy and cy ...... Aspergillus flavus infections
@ast
Differences in efficacy and cy ...... Aspergillus flavus infections
@en
type
label
Differences in efficacy and cy ...... Aspergillus flavus infections
@ast
Differences in efficacy and cy ...... Aspergillus flavus infections
@en
prefLabel
Differences in efficacy and cy ...... Aspergillus flavus infections
@ast
Differences in efficacy and cy ...... Aspergillus flavus infections
@en
P2093
P2860
P356
P1476
Differences in efficacy and cy ...... Aspergillus flavus infections
@en
P2093
J P Adler-Moore
J Schwartz
R T Proffitt
P2860
P304
P356
10.1128/AAC.00607-11
P407
P577
2011-10-03T00:00:00Z